These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 2093532)

  • 41. Treatment of the anemia of progressive renal failure with recombinant human erythropoietin.
    Eschbach JW; Kelly MR; Haley NR; Abels RI; Adamson JW
    N Engl J Med; 1989 Jul; 321(3):158-63. PubMed ID: 2747747
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Randomized prospective comparison between erythropoietin and androgens in CAPD patients.
    Navarro JF; Mora C; Macía M; García J
    Kidney Int; 2002 Apr; 61(4):1537-44. PubMed ID: 11918762
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Blood rheology and hypertension in hemodialysis patients treated with erythropoietin.
    Schaefer RM; Leschke M; Strauer BE; Heidland A
    Am J Nephrol; 1988; 8(6):449-53. PubMed ID: 3218658
    [TBL] [Abstract][Full Text] [Related]  

  • 44. rHuEpo before dialysis and in dialysed patients.
    López-Gómez JM; Jofre R; Moreno F; Verde E; Valderràbano F
    Nephrol Dial Transplant; 1995; 10 Suppl 6():31-5. PubMed ID: 8524491
    [No Abstract]   [Full Text] [Related]  

  • 45. Iron metabolism under rEPO therapy in patients on maintenance hemodialysis.
    Bergmann M; Grützmacher P; Heuser J; Kaltwasser JP
    Int J Artif Organs; 1990 Feb; 13(2):109-12. PubMed ID: 2347653
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hemodynamic and volume changes by recombinant human erythropoietin (rHuEPO) in the treatment of anemic hemodialysis patients.
    Hori K; Onoyama K; Iseki K; Fujimi S; Fujishima M
    Clin Nephrol; 1990 Jun; 33(6):293-8. PubMed ID: 2376091
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Normalization of elevated prolactin levels in hemodialysis patients on erythropoietin.
    Schaefer RM; Kokot F; Kürner B; Zech M; Heidland A
    Nephron; 1988; 50(4):400-1. PubMed ID: 3237289
    [No Abstract]   [Full Text] [Related]  

  • 48. Long-term echocardiographic examinations in chronic hemodialysis patients substituted with recombinant human erythropoietin.
    Löw-Friedrich I; Grützmacher P; März W; Bergmann M; Schoeppe W
    Blood Purif; 1990; 8(5):272-8. PubMed ID: 2151114
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Erythropoietin overview--1993.
    Nissenson AR
    Blood Purif; 1994; 12(1):6-13. PubMed ID: 7986477
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [A multicenter trial of Recormon within the framework of international controlled research].
    Tareeva IE; Nikolaev AIu; Klepikov PV; Lashutin SV; Riabov SI; Shostka GD; Ermolenko VM; Rozental' RL; Vorob'ev PA; Miagkov AV
    Ter Arkh; 1992; 64(8):59-62. PubMed ID: 1440400
    [No Abstract]   [Full Text] [Related]  

  • 51. [Cerebrovascular incidents in 4 hemodialysis patients treated with erythropoietin].
    Zehnder C; Blumberg A
    Schweiz Med Wochenschr; 1988 Oct; 118(40):1423-6. PubMed ID: 3187475
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of recombinant human erythropoietin on the anemia of chronic renal failure.
    Urabe A; Takaku F; Mizoguchi H; Kubo K; Ota K; Shimizu N; Tanaka K; Mimura N; Nihei H; Koshikawa S
    Int J Cell Cloning; 1988 May; 6(3):179-91. PubMed ID: 3397592
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dialysis dose, membrane type, and anemia control.
    Young EW
    Am J Kidney Dis; 1998 Dec; 32(6 Suppl 4):S157-60. PubMed ID: 9892384
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [The correction of anemia with a high requirement for transfusion in patients on maintenance hemodialysis by conventional and reduced doses of recombinant human erythropoietin].
    Sivak L; Scuteri RM; Cavalli NH; Gotlieb D; López Blanco OA
    Medicina (B Aires); 1992; 52(6):516-22. PubMed ID: 1340900
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Erythropoietin therapy for anemia of prematurity.
    Gallagher PG; Ehrenkranz RA
    Clin Perinatol; 1993 Mar; 20(1):169-91. PubMed ID: 8458164
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of recombinant human erythropoietin administration on immunological indices in patients undergoing chronic hemodialysis.
    Yorioka N; Hamaguchi N; Takasugi N; Shigemoto K; Harada S; Fujiwara K; Ishida A; Maeda T; Kawai A; Yamakido M
    Nihon Jinzo Gakkai Shi; 1993 Aug; 35(8):981-8. PubMed ID: 8255010
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Sexual function with and without erythropoietin therapy.
    Odone P; Boccalatte G; Ortensia A; Iberti M; Tafuri A
    Int J Artif Organs; 1992 Jul; 15(7):440-1. PubMed ID: 1516997
    [No Abstract]   [Full Text] [Related]  

  • 58. [Countermeasure for patients with anemia due to hemodialysis].
    Suzuki M
    Nihon Naika Gakkai Zasshi; 1995 Oct; 84(10):1663-7. PubMed ID: 8537721
    [No Abstract]   [Full Text] [Related]  

  • 59. Erythropoietin for anemia of renal failure in sickle cell disease.
    Steinberg MH
    N Engl J Med; 1991 May; 324(19):1369-70. PubMed ID: 1759999
    [No Abstract]   [Full Text] [Related]  

  • 60. A study of platelet functions, some hemostatic and fibrinolytic parameters in relation to serotonin in hemodialyzed patients under erythropoietin therapy.
    Malyszko J; Malyszko JS; Borawski J; Rydzewski A; Kalinowski M; Azzadin A; Mysliwiec M; Buczko W
    Thromb Res; 1995 Jan; 77(2):133-43. PubMed ID: 7740505
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.